Quantbot Technologies’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9K Buy
+123
New +$3.64K ﹤0.01% 1870
2024
Q2
Sell
-1,500
Closed -$97.5K 1663
2024
Q1
$97.5K Buy
+1,500
New +$103K 0.01% 1180
2023
Q2
Sell
-1,800
Closed -$89K 1742
2023
Q1
$89K Sell
1,800
-5,600
-76% -$315K 0.01% 1123
2022
Q4
$422K Buy
7,400
+3,218
+77% +$181K 0.03% 639
2022
Q3
$196K Buy
+4,182
New +$199K 0.01% 886

Other funds holding IMCR

Quantbot Technologies's IMCR Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Immunocore (IMCR) in Q2 2026: 123 shares worth $3.9K. The stake represents ﹤0.01% of the portfolio and ranks #1870 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in IMCR as recently as Q1 2024.

Quantbot Technologies first reported a position in IMCR in Q3 2022 and has held it in 5 quarters since. The position peaked at $422K in Q4 2022. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Quantbot Technologies held 123 shares of Immunocore worth $3.9K as of Q2 2026.
  • Immunocore was a new Quantbot Technologies position in Q2 2026.
  • Immunocore made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1870 holding.
  • Quantbot Technologies first reported a position in Immunocore in Q3 2022 and has held it in 5 quarters since.
  • Quantbot Technologies's Immunocore position peaked at $422K in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.